CHG-2021-0076
Analytical Method Change for Retinavab. Formulation Change for Retinavab — minor update. Impacts 8 markets and 2 variations.
Change Number
CHG-2021-0076
Type
Analytical Method Change
Product
Status
Active
Owner
Dmitri Volkov
Initiated
2023-01-04
Description
Formulation Change for Retinavab — minor update
Impacted Markets (8)
JP — JapanCN — ChinaAR — ArgentinaTR — TurkeyPL — PolandSE — SwedenBE — BelgiumPT — Portugal
Impacted Modules
3.2.S3.2.P
Linked Variations (2)
| Variation # | Type | Application | Status | Submitted | Approved |
|---|---|---|---|---|---|
| TITCK-2024-0076-V376 | Type II | TITCK-2024-0076 | Active | — | — |
| SFDA-2023-0077-V377 | Minor | SFDA-2023-0077 | Overdue | — | — |